Greer Loveman-Krelle
Family · Sherman Oaks, CANPI 1992331326
Payments from drug & device makers
Across 454 payments — averaging $15.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Bausch Health US, LLC$1K
- Novo Nordisk$501
- Lilly USA, LLC$491
- Amgen$463
- Mayne Pharma Commercial LLC$335
- plus $3K from 29 others
What the payments were for
- Food & beverage$7,229100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 117 | $1,900 |
| Bausch Health US, LLC | 99 | $1,012 |
| Novo Nordisk | 39 | $501 |
| Lilly USA, LLC | 37 | $491 |
| Amgen(2 entities) | 21 | $463 |
| Mayne Pharma Commercial LLC | 30 | $335 |
| Akebia Therapeutics Inc | 8 | $257 |
| Fresenius USA Marketing, Inc. | 14 | $232 |
| IBSA Pharma Inc. | 12 | $220 |
| Pfizer | 10 | $186 |
| Exact Sciences | 10 | $177 |
| AstraZeneca | 8 | $161 |
| Abbott | 1 | $134 |
| Bayer | 1 | $120 |
| Alkermes, Inc. | 1 | $120 |
| GSK | 5 | $90 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Boehringer Ingelheim | 3 | $70 |
| Merck | 3 | $65 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $62 |
| Therapeuticsmd, Inc. | 4 | $62 |
| Novartis | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Hologic Sales And Service, LLC | 2 | $39 |
| Phadia US Inc. | 2 | $35 |
| Idorsia Pharmaceuticals US Inc | 2 | $33 |
| Medicure Pharma Inc. | 1 | $27 |
| Biogen | 1 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $23 |
| Angiodynamics, Inc. | 1 | $22 |
| Exeltis, USA Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,229 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VelphoroSucroferric Oxyhydroxide | 35 | $82,060 |
| Sevelamer Hcl | 27 | $44,057 |
| AuryxiaFerric Citrate | 11 | $26,976 |
| RybelsusSemaglutide | 15 | $13,685 |
| Sevelamer Carbonate | 33 | $12,184 |
| TradjentaLinagliptin | 11 | $9,567 |
| EliquisApixaban | 11 | $7,684 |
| LokelmaSodium Zirconium Cyclosilicate | 12 | $6,498 |
| ProsolParenteral Amino Acid 20% No.1 | 45 | $5,596 |
| Calcium Acetate | 47 | $3,299 |
| Nifedipine ErNifedipine | 30 | $633 |
| Levothyroxine Sodium | 92 | $615 |
| Amlodipine Besylate | 80 | $602 |
| Wixela InhubFluticasone Propion/Salmeterol | 13 | $600 |
| Atorvastatin Calcium | 59 | $527 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Fresenius USA Marketing, Inc.Velphoro | $232 | $82,06035 claims |
| Akebia Therapeutics IncAuryxia | $257 | $26,97611 claims |
| Novo NordiskRybelsus | $501 | $13,68515 claims |
| Boehringer IngelheimTradjenta | $70 | $9,56711 claims |
| PfizerEliquis | $186 | $7,68411 claims |
| AstraZenecaLokelma | $161 | $6,49812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,634 family providers in California.
Other family in Sherman Oaks
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.